Symbol="XBIT"
AssetType="Common Stock"
Name="XBiotech Inc"
Description="XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas."
CIK="1626878"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8201 E. RIVERSIDE DRIVE, BUILDING 4, SUITE 100, AUSTIN, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="156439000"
EBITDA="-32898000"
PERatio="None"
PEGRatio="0"
BookValue="7.53"
DividendPerShare="0"
DividendYield="0"
EPS="-0.85"
RevenuePerShareTTM="0.065"
ProfitMargin="0"
OperatingMarginTTM="-17.65"
ReturnOnAssetsTTM="-0.0871"
ReturnOnEquityTTM="-0.117"
RevenueTTM="1980000"
GrossProfitTTM="3359000"
DilutedEPSTTM="-0.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.933"
AnalystTargetPrice="18"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.9"
PriceToBookRatio="0.405"
EVToRevenue="0.686"
EVToEBITDA="3.944"
Beta="1.213"
num_52WeekHigh="6.69"
num_52WeekLow="3"
num_50DayMovingAverage="5.37"
num_200DayMovingAverage="4.2"
SharesOutstanding="30435700"
DividendDate="2021-07-23"
ExDividendDate="2021-07-15"
symbol="XBIT"
open="5.13"
high="5.15"
low="4.89"
price="4.98"
volume="31570.00"
latest_trading_day="2023-08-30"
previous_close="5.15"
change="-0.17"
change_percent="-3.3010%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="37"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="65420"
Change_recent_avg="0.01"
Delta_recent_avg="0.32"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="519"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_negative_thumbnail_id_2="515"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="679"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_positive_thumbnail_id_2="1007"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0169.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
